TransMedics(TMDX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 TransMedics Reports Third Quarter 2024 Financial Results Andover, Mass. – October 28, 2024 – TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2024. Recent Highlights ▪ Total revenue of $108.8 million in the third quarter of 2024, a 64% increase compared to the third quarter of 2023 ▪ Gen ...